Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- Neurimmune AG
- Target Recruit Count
- 46
- Registration Number
- NCT04360434
- Locations
- 🇫🇷
Hôpital Henri Mondor, Créteil, France
🇫🇷CHU de Rennes - Hôpital Pontchaillou, Rennes, France
🇫🇷CHU Toulouse - Hôpital Rangueil, Toulouse, France
News
No news found